latest news in companies

Bitfarms Faces Legal Scrutiny Over Financial Restatements

Bitfarms Faces Legal Scrutiny Over Financial Restatements

Toronto, Tuesday, 1 April 2025.
Rosen Law Firm investigates potential class action for Bitfarms investors after financial restatements were announced, impacting stock prices by 6%. No upfront legal fees for participants.

Electronic Arts Faces Securities Investigation Amid Stock Decline

Electronic Arts Faces Securities Investigation Amid Stock Decline

Redwood City, Sunday, 30 March 2025.
Rosen Law Firm is investigating potential securities claims against Electronic Arts after a 16.3% stock drop, citing allegedly misleading business information. Investors experienced significant losses this year.

Fosun International Reports Strong 2024 Revenue Amid Economic Challenges

Fosun International Reports Strong 2024 Revenue Amid Economic Challenges

Shanghai, Sunday, 30 March 2025.
Fosun International achieved RMB192.14 billion in revenue in 2024, with core operations remaining stable despite a one-off loss. Their focus on innovation and globalization drives continued growth.

Faruqi & Faruqi Investigates Investor Claims in Major Firms: Potential Legal Fallout

Faruqi & Faruqi Investigates Investor Claims in Major Firms: Potential Legal Fallout

New York City, Sunday, 30 March 2025.
Faruqi & Faruqi investigates investor claims against prominent companies e.l.f. Beauty and Merck, focusing on alleged security law violations. The inquiries could lead to significant financial implications.

GivBux Invests $212 Million to Boost Expansion Efforts

GivBux Invests $212 Million to Boost Expansion Efforts

Newport Beach, Saturday, 29 March 2025.
GivBux commits $212 million to an asset-based vehicle aimed at global expansion, marking a pivotal shift towards income-generating strategies to support its Super App growth.

Novo Nordisk's Rybelsus Shows Promise in Reducing Cardiovascular Events

Novo Nordisk's Rybelsus Shows Promise in Reducing Cardiovascular Events

Copenhagen, Saturday, 29 March 2025.
Novo Nordisk’s Rybelsus reduced major cardiovascular events by 14% in type 2 diabetes patients, as revealed in the SOUL trial at ACC 2025.

Fluence Energy Investors Offered Chance to Lead Class Action Lawsuit

Fluence Energy Investors Offered Chance to Lead Class Action Lawsuit

N/A, Saturday, 29 March 2025.
Fluence Energy investors facing significant losses invited to lead class action lawsuit. Allegations include misleading financial statements and relationships, prompting a substantial stock price fall. Deadline for lead plaintiff is May 12, 2025.

AAR Corp. Sees 20% Sales Surge Despite Reporting Net Loss in Q3 2025

AAR Corp. Sees 20% Sales Surge Despite Reporting Net Loss in Q3 2025

Wood Dale, Friday, 28 March 2025.
AAR Corp. witnessed a remarkable 20% year-over-year sales increase to $678 million in Q3 2025, but faced a GAAP net loss of $9 million, demonstrating significant operational efficiency improvements with adjusted EBITDA growth of 39%.

Seabridge Gold Reports 2024 Loss Amidst Strategic Investments

Seabridge Gold Reports 2024 Loss Amidst Strategic Investments

Toronto, Friday, 28 March 2025.
Seabridge Gold Inc. reported a net loss of CAD 31.2 million for 2024, contrasting some erroneous reports of profits. Strategic investments and equity financings were pivotal this fiscal year.

AAR Corp Reports Strong Q3 Sales Growth Amid Mixed Earnings

AAR Corp Reports Strong Q3 Sales Growth Amid Mixed Earnings

Wood Dale, Friday, 28 March 2025.
Despite a $678 million 20% sales increase, AAR Corp’s Q3 results showed a $9 million net loss due to a significant pre-tax charge. Adjusted EPS exceeded expectations at $0.99.